Three and two drugs inhibition of Renin-Angiotensin-Aldosterone System (RAAS) in treatment of diabetic nephropathy
Not Applicable
- Conditions
- diabetic nephropathy.Glomerular disorders in diabetes mellitus
- Registration Number
- IRCT138901293742N1
- Lead Sponsor
- Tabriz university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 103
Inclusion Criteria
proteinuria, impaired renal function in diabetic patients. Exclusion criteria: pregnancy, milking, drug allergy, bilateral renal artery stenosis, ESRD, beta blocker contraindication, patient rejection.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proteinuria. Timepoint: one month. Method of measurement: urine exam.;Kidney function. Timepoint: one month. Method of measurement: urine and blood exam.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: one month. Method of measurement: blood pressure measurment by sphygmomonometere.;Blood potassum. Timepoint: one month. Method of measurement: Blood Biochemistery.;HgA1c. Timepoint: one month. Method of measurement: Blood biochemistery.;Na. Timepoint: one month. Method of measurement: Blood biochemistery.